Markets:

Overview

News

Currencies

International

Treasuries

CryoPort, Inc. - Common Stock (NQ:CYRX)

8.115 +0.025 (+0.31%)

Streaming Delayed Price Updated: 10:49 AM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CryoPort, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Biotech Stocks are Due for a Rally ↗

November 22, 2021

There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.

Via Talk Markets

4 Stocks Insiders Are Selling ↗

November 19, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

Looking for Growth in Small and Mid Cap Life Science Stocks ↗

November 15, 2021

2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.

Via Talk Markets

CryoPort Inc (CYRX) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

CYRX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: CryoPort Q3 Earnings ↗

November 04, 2021

CryoPort (NASDAQ:CYRX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings CryoPort...

Via Benzinga

3 Under-the-Radar COVID Stocks ↗

October 20, 2021

Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.

Via The Motley Fool

Chief Financial Officer Of Cryoport Trades $3.8M In Company Stock ↗

October 18, 2021

Robert Stefanovich, Chief Financial Officer at Cryoport (NASDAQ:CYRX), made a large buy and sell of company shares on October 14, according to a new SEC filing. What Happened: A...

Via Benzinga

Topics Regulatory Compliance

Biotech Playbook Revisited As Technicals Weaken ↗

September 27, 2021

Recent breakthroughs with mRNA vaccines over the past two years have shown the enormous potential for transformative therapies. DNA sequencing took off five years ago and new applications are still...

Via Talk Markets

Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market ↗

September 09, 2021

Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.

Via Talk Markets

Return on Capital Employed Overview: CryoPort ↗

August 31, 2021

After pulling data from Benzinga Pro it seems like during Q2, CryoPort (NASDAQ:CYRX) brought in sales totaling $56.19 million. However, earnings decreased 228.2%, resulting in a...

Via Benzinga

5 Stocks Insiders Are Selling ↗

August 27, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

Cryoport, Mitsubishi Logistics Partner For Temperature-Controlled Supply Chain Solutions ↗

August 25, 2021

Cryoport Inc (NASDAQ: CYRX) and Mitsubishi Logistics Corporation (MLC) entered a multi-year strategic business alliance to create an integrated...

Via Benzinga

Vaccine Victory ↗

August 24, 2021

Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson...

Via Talk Markets

Topics Economy

Mid-Cap Biotech Picks: Seasonal Rally Underway ↗

July 03, 2021

Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.

Via Talk Markets

Healthcare Portfolio Playbook: Time To Rebalance With MedTech ↗

June 18, 2021

As we look to re-balance our portfolio in the near-term, investors should consider adding Medtech as we have suggested in the past. Though, more recently, we have also focused on large-cap...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021 ↗

July 16, 2021

Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE:

Via Benzinga

Biotech Movers During ASCO Week ↗

June 12, 2021

The biotech sector performed well in a good ASCO week. And many biotech stocks were movers this week as a bullish sentiment took hold sparked by the Biogen Aduhelm approval.

Via Talk Markets

Not Just GameStop, WallStreetBets' Target Melvin Capital Closed All Public Short Positions In Q1 ↗

May 19, 2021

Hedge fund Melvin Capital Management LP, which was at the heart of the GameStop Corp. (NYSE: GME) short squeeze frenzy earlier this year, closed out of all its public short...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 05, 2021

Gainers Chiasma (NASDAQ:CHMA) shares moved upwards by 41.9% to $4.03 during Wednesday's regular session. Chiasma's stock is trading at a volume of 75.5 million...

Via Benzinga

A Preview Of CryoPort's Earnings ↗

May 03, 2021

On Tuesday, May 04, CryoPort (NASDAQ:CYRX) will release its latest earnings report. Benzinga's outlook for CryoPort is included in the following report. Net Income, Earnings, And...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.